Clinical cancer research : an official journal of the American Association for Cancer Research
Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial.
Ralph G Zinner, Eric V Mastrolonardo, Jennifer M Johnson, Kathryn Nunes, Pablo Llerena, Zachary Elliott, Madalina Tuluc, Joseph M Curry, Christopher E Fundakowski, Andrew Yampolsky, Richard Goldman, Charalambos C Solomides, Stacey M Gargano, Haresh Naringrekar, Larry Harshyne
Published: 202510.1158/1078-0432.CCR-25-2807
Abstract
BACKGROUND: In locally-advanced resectable squamous cell carcinoma of the head and neck (SCCHN), patients treated with neoadjuvant chemotherapy with major pathologic response (MPR) or pathologic complete response (pCR) have overall survival (OS) rate…
Preview only. Read the full abstract at the source